Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Mangoceuticals (MGRX) Gross Profit (2023 - 2025)

Mangoceuticals (MGRX) has disclosed Gross Profit for 3 consecutive years, with $47475.0 as the latest value for Q4 2025.

  • Quarterly Gross Profit fell 40.73% to $47475.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $250386.0 through Dec 2025, down 34.1% year-over-year, with the annual reading at $250386.0 for FY2025, 34.1% down from the prior year.
  • Gross Profit hit $47475.0 in Q4 2025 for Mangoceuticals, down from $50899.0 in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $147398.0 in Q1 2024 to a low of $47475.0 in Q4 2025.
  • Historically, Gross Profit has averaged $88487.6 across 3 years, with a median of $81387.0 in 2024.
  • Biggest five-year swings in Gross Profit: soared 157.69% in 2024 and later plummeted 57.89% in 2025.
  • Year by year, Gross Profit stood at $142583.0 in 2023, then tumbled by 43.82% to $80103.0 in 2024, then plummeted by 40.73% to $47475.0 in 2025.
  • Business Quant data shows Gross Profit for MGRX at $47475.0 in Q4 2025, $50899.0 in Q3 2025, and $89948.0 in Q2 2025.